- Active not recruitingPHASE2
A Follow-on Study for Second-Eye Treatment for Participants Previously Treated With Gene Therapy for X-Linked Retinitis Pigmentosa (XLRP)
This study is for people who have already had gene therapy for an eye condition called X-linked Retinitis Pigmentosa (XLRP). It looks at how safe and effective the same treatment is when given to their other eye, and how they get on with it over time.
For: X-Linked Retinitis PigmentosaUnited States · United Kingdom - CompletedPhase II
A follow-on study for second-eye treatment for participants previously treated with gene therapy for X-Linked Retinitis Pigmentosa (XLRP)
This study is for men with a serious eye condition called X-linked Retinitis Pigmentosa (XLRP) who have already received gene therapy in one eye. It aims to see if giving the same treatment to their second eye is safe and how well it's tolerated, hoping to improve or protect their vision.
For: X-Linked Retinitis PigmentosaUnited Kingdom